for the Biomedical Excellence for Safer Transfusion Collaborative (BEST) Investigators
BACKGROUND: Some countries impose an upper age limit on whole blood and double RBC donation while others do not. We evaluated the safety of blood donation in older individuals (≥71 years), and their contribution to the blood supply of five countries.
STUDY DESIGN AND METHODS:
Twelve blood center members of the Biomedical Excellence for Safer Transfusion (BEST) Collaborative from four countries with no upper age limit for whole blood and double RBC donation (Canada, New Zealand, England, and the United States) or an upper age limit of 80 (Australia) provided 2016 data on donors and donations, deferral rates, and vasovagal reactions by donor age and sex. Donors under age 24 were included in the number of total donors and donations, but not in deferral and reaction rate comparisons.
RESULTS:
Older donors accounted for 1.0% (New Zealand) to 4.3% (United States) of donors, and 1.5% (New Zealand) to 5.6% (United States) of donations; most were between ages 71 and 76. The deferral rate was higher in older compared to 24-to 70-year-old males, but very similar between older and younger females. In contrast, vasovagal reaction rates were either lower (male donors) or similar (female donor for reactions with loss of consciousness) in older compared to 24-to 70-year-old donors.
CONCLUSIONS: Exclusion solely based on older age appears to be unwarranted based on safety concerns such as donor reactions. Healthy older individuals can continue to safely donate and make a significant contribution to the blood supply past arbitrary age limits.
B
lood donor selection criteria are important to protect the health of both donors and transfusion recipients. However, criteria designed to protect donor health are often based on past practice and experience rather than on actual evidence and current knowledge, and these criteria can vary between countries with similar donor populations. Criteria regarding an upper age limit may have an important impact on the potential donor pool in countries with an aging donor population, and vary considerably among developed countries.
1,2
The Biomedical Excellence for Safer Transfusion (BEST) Collaborative is in a unique position to bring together data from multiple countries to assess the current contribution of older donors to the blood supply internationally and the safety of donation for these donors. An earlier study on donor and general population demographics found that the upper age limit varied from 69 to 80, with many blood centers having an upper age limit of 70; other centers had no upper age limit. 3 The aims of this analysis are to 1) assess the contribution that older donors make to the blood supply in four countries that do not have an upper limit for blood donation and in one with an upper age limit of 80 years; 2) evaluate deferral rates for hemoglobin (Hb), vital signs, and donor history in donors in the 24-to 70-year-old age group versus older donors; and 3) compare reaction rates in 24-to 70-year-old donors to rates in donors aged 71 or older. Donors under age 24 were included in the overall number of donors and donations in each country, but were not included in comparisons of deferral and reaction rates. Younger donors have significantly higher vasovagal reaction rates and different deferral patterns and comprise a highly variable proportion of each country's donor base. [3] [4] [5] Although the choice of a cutoff age is somewhat arbitrary, the vasovagal reaction rate decreases substantially in donors over 23. 4, 5 Additionally, some of the contributing centers have more stringent minimum estimated blood volume criteria for donors under age 24, while others do not. Comparisons are most appropriate between age groups within a country to control for variable deferral policies and donor reaction definitions between countries. This analysis may assist countries reevaluating their current donor eligibility policies with respect to donor age.
MATERIALS AND METHODS
Blood center members of BEST with no upper age limit for donation or an upper age limit of 80 were invited to participate in the study and were asked to provide the number of male and female allogeneic whole blood and The data from the seven US centers were combined to give the US numbers. Participating centers also provided data on the number of individuals deferred for low Hb, vital signs (if performed), and other donor history criteria for 24-to 70-year-old and older individuals. Some centers do not perform measurement of donor vital signs, while others perform a combination of donor blood pressure and/or pulse and/or temperature assessment. Donor history deferrals include all deferrals based on the donor assessment questionnaire and may be temporary or permanent. Finally, centers provided the number of all vasovagal reactions and vasovagal reactions with loss of consciousness (LOC) in males and females from their donor reaction databases for 24-to 70-year-old and older donors. Double RBC donations were counted as the equivalent of two whole blood donations to fully quantify their contribution to the blood supply, but as one donation in comparisons of deferral and reaction rates. Australia and New Zealand do not collect double RBC donations.
Statistical analysis
To determine the percentage of the blood supply contributed by older donors, the total number of blood donors and total number of donations for each country was calculated by adding the number of male and female allogeneic whole blood donors and donations for calendar year 2016 for donors under age 24, age 24 to 70, or over age 70. Additionally, for the US, double RBC donations were counted as two donations in the total number of donations. The percentage of donors or donations made by those aged 71 and older was calculated overall and by sex. The percentage of older donors by age category was calculated using the number of donors in the specific category (e.g., 71-72) in the numerator and the total number of donors aged 71 or older in the denominator.
Donors under age 24 were not included in calculations of deferral and reaction rates. Deferral rates were calculated at the donor/individual level with the total number of individuals aged 24 to 70 years old deferred for Hb divided by the total number of donors aged 24 to 70 years old, and the same done for the 71 and older age groups and other deferrals. Deferral rates were separated into two categories: Hb below cutoff, and all other deferrals (donor history questionnaire, vital signs if performed, and for some centers, inadequate veins). The statistical significance of comparisons in deferral rates between age groups in each country was determined by chi-square. Odds ratios for vasovagal reactions (all vasovagal reactions and those with LOC only) and 95% confidence intervals (CIs) were calculated for younger (age 24 to 70) and older donor (age 71 and older) groups by sex, using normal approximation. Some blood centers record all vasovagal reactions, while others record only reactions judged to be moderate and severe. Analyses were done using Cochran-Mantel-Haenszel test and twosided p values, using a significance level of p less than 0.05. Table 1 summarizes the number and percentage of donors and donations and the mean number of donations per year by donor age (≤70 vs. ≥71) and sex. The minimum age limit and proportion of donors under age 24 varies in different countries. In the US centers, double RBC donations make up 19.1% of all donations. Older donors accounted for 1.0% to 4.2% of the donor population and contributed 1.5% to 5.6% of donations in each country. In all countries, there were more older male donors than older female donors (total of 119,227 older male vs. 87,195 older female donors; p < 0.0001). Male donors accounted for 45% to 50% of donors and 46% to 56% of donations from donors below age 71 and 55% to 65% of donors and 58% to 69% of donations from donors over 70. In all countries, male and female older donors donated more frequently than younger donors (p < 0.0001; Table 1 ). Figure 1 illustrates the distribution of donors over age 70. Most older donors are in the 71 to 76 age categories (United States, 69%; United Kingdom, 87%; New Zealand, 100%; Australia, 92%; Canada, 88%). The United States has the largest proportion of donors over age 80 (United States, 12%; Canada, 3%; United Kingdom, New Zealand, and Australia, 0%). Figure 2 shows the deferral rates in males and females in the over 70 versus 24-to 70-year-old age group. For males, the deferral rate for both Hb and all other deferrals was higher in the older donor group in all countries. Overall deferral rates ranged from 6.3% to 13.7% in 24-to 70-yearold males, and 9.8% to 18.4% for males over 70 (p < 0.001 for all except New Zealand, p = 0.02). For females, the Hb deferral rate was slightly higher in older donors in the United States, United Kingdom, and Australia, and lower in older donors in New Zealand and Canada. For other deferrals, the deferral rate was higher for the older age group in the United Kingdom and Canada. Therefore, overall deferral rates were very similar in each country for younger and older female donors, ranging from 9.5% to 17% in 24-to 70-year-old females, and 9.2% to 21.0% for females over 70 (p < 0.05 for the United States, United Kingdom, and Canada, and >0.8 for New Zealand and Australia).
RESULTS
The odds ratios (and 95% CIs) of all vasovagal reactions recorded in the centers' databases, as well as vasovagal reactions with LOC are shown in Fig. 3A (males) and Fig. 3B (females). For all countries except New Zealand, vasovagal reactions and vasovagal reactions with LOC were less common in older compared to younger males. The number of vasovagal reactions with LOC was very small in New Zealand, making the CI extremely broad and analysis difficult. Vasovagal reactions in females were lower in older compared to 24-to 70-year old donors (Fig. 3B) . However, for vasovagal reactions with LOC, in most countries the 95% CI crosses 1, demonstrating that these reactions were just as frequent in female donors in the two age categories. Because the number of vasovagal reactions with LOC is small, confidence intervals are large, particularly for New Zealand, where the total number of donations made by older female donors is also small (two vasovagal reactions with LOC out of 718 donations from females over age 70).
DISCUSSION
Establishing blood center criteria to ensure donor safety is not an exact science. Often, criteria are based on "common sense" or experience, rather than on evidence. As blood centers became more regulated over time, these practices have been codified in professional standards and regulations, making it impossible to accumulate any further information about safety in these ineligible donor groups. Using data from 12 blood centers across five different countries, our study shows that healthy older individuals can continue to safely donate and make a significant contribution to the blood supply. Hence, in the current context, exclusion solely based on older age appears to be unnecessary. Although health concerns more common in older people will render some older donors ineligible for donation, our study suggests that the combination of other donor selection criteria and the donors' own assessment of suitability largely excludes donors at risk for an adverse reaction.
A previous study performed by the BEST Collaborative donor group demonstrated variable lower and upper limits for donation for first-time and repeat donors in different countries. 3 The US Food and Drug Administration does not specify an upper age limit for blood donation. Historically, US blood centers have considerable experience with older donors who often had multiple comorbidities due to large autologous donation programs operating through the 1980s and 1990s. 6 Most US blood centers therefore removed their individual upper age limits for volunteer allogeneic donors' decades ago. The Council of Europe does not specify an upper age limit, but the 19th edition of the European Directorate Guide to the preparation, use, and quality assurance of blood components specifies that donation by first-time donors over age 60 and repeat donors over age 65 is at the discretion of the responsible physician. 7 Individual countries may also have their own regulatory requirements; this was the case in Canada until 2004. 8 Many countries are experiencing aging of both their general population and their donor population, with a large cohort of late-middle-aged Baby Boomers entering their 70s. 3, [9] [10] [11] [12] Indiscriminately deferring these donors as they hit an upper age limit, even if they meet all other donor criteria, may result in the loss of many dedicated, safe donors. In an era when information on donor criteria is available on most blood centers' Web sites, and donors may spend considerable periods of time in other countries with different criteria, an upper age limit may also generate complaints of age discrimination. This was the case in Canada before 2004, when many "snowbirds" successfully donated blood during their winter stay in the United States but were deferred due to an upper age limit when they returned home.
Older donors make up from 1% to 4% of the donor base, donate more frequently than younger donors, and are more likely to be male. Most are between 71 and 76 years old. The larger proportion of American donors over age 80 is likely due to absence of an upper age limit to donation for a longer time period in the United States, compared to Canada and the United Kingdom, while Australia does not accept donors over age 80.
Older males are more likely to be deferred than younger ones. Higher Hb deferrals may in part be related to the decline in normal Hb levels with age. 13 Because they donate more frequently or develop chronic health conditions, older males may also be more likely to become iron deficient. The difference in overall deferral rates is minimal between older and younger females. Hb deferral rates are similar or slightly higher or lower in older compared to younger females in different countries. This is likely due to higher levels of iron deficiency anemia in premenopausal women. 14 Depending on the country, deferral rates based on vital signs and the donor health questionnaire are stable or increased to some extent in older donors; this may in part reflect different eligibility criteria for health conditions, such as cardiac disease or a history of cancer, that are more common in the older donor population. Despite these small differences, most donor presentations from older donors result in a successful donation. Finally, and most importantly, donation appears to be safe in older donors. The odds ratios for both all recorded vasovagal reactions, and vasovagal reactions with LOC are lower (all vasovagal reactions in males and females, vasovagal reactions with LOC reactions in males) or similar (LOC reactions in females) in older donors, compared to 24-to 70-year-old donors. These results are concordant with studies performed by blood centers in Germany, Canada, and the United States on the safety of blood donation in older donors. 4, 5, 8, [15] [16] [17] Although it is possible that there are other physiologic effects of donation that have a greater impact in older adults, individuals who continue to donate into their 70s likely tolerate donation particularly well. Our study has several strengths. Results include over 488,000 donations from over 200,000 older donors and are consistent across five different countries that all have slightly different donor clinic procedures and eligibility criteria. This provides increased assurance of the safety of donation in older individuals. Our study also has some limitations. As each blood center uses different definitions and reporting practices, reported reaction rates may include all or a subset of vasovagal reactions. We do not have sufficient information about donor base composition, eligibility criteria, or adverse donor reaction reporting in each country to compare rates between countries. However, the same conditions apply to both younger and older donor groups in each country such that they are comparable within a given country. For some countries, such as New Zealand, the number of donations made by donors over age 70 was low, 
LOC and all vasovagal reactions in males (A) and females (B).
A ratio <1 indicates a higher reaction rate in younger donors, while a ratio >1 indicates a higher reaction rate in older donors.
Volume 59, April 2019 TRANSFUSION 1271 so that for rare events, such as vasovagal reactions with LOC, CIs for rates were large. We did not distinguish between first-time and repeat donors, in part because in the United States, first-time donors at a given blood center may have simply relocated from another jurisdiction and not truly be donating for the first time. In all countries, it is likely that very few donors over age 70 are donating for the first time; therefore, conclusions about safety apply primarily to repeat donors. Older individuals who can continue donating are obviously a small, healthy subset of the overall population of older individuals. However, there is nothing in these data to suggest that a first donation cannot be made safely after the age of 70.
In conclusion, this large, multinational study suggests that healthy older individuals can continue to safely donate and make a significant contribution to the blood supply.
